Measurements and Main Results: The primary endpoint of the interventio的简体中文翻译

Measurements and Main Results: The

Measurements and Main Results: The primary endpoint of the interventional part was change in urinary [tissue inhibitor of metalloproteinases-2]*[insulin-like growth factor–binding protein 7] between pre- and postintervention. To examine secondary objectives including acute kidney injury incidence, we included an observational cohort. A total of 180 patients were included in the trial (n = 80 observational and n = 100 randomized controlled part [20 patients/group]). The mean age was 69.3 years (10.5 yr), 119 were men (66.1%). Absolute changes in [tissue inhibitor of metalloproteinases-2]*[insulin-like growth factor–binding protein 7] were significantly higher in all remote ischemic preconditioning groups when compared with controls (p < 0.01). Although we did not observe a dose-response relationship on absolute changes in [tissue inhibitor of metalloproteinases-2]*[insulin-like growth factor–binding protein 7] across the four different remote ischemic preconditioning groups, in the 15 patients failing to respond to the lowest dose, nine (60%) responded to a subsequent treatment at a higher intensity. Compared with controls, fewer patients receiving remote ischemic preconditioning developed acute kidney injury within 72 hours after surgery as defined by both Kidney Disease: Improving Global Outcomes criteria (30/80 [37.5%] vs 61/100 [61.0%]; p = 0.003).
0/5000
源语言: -
目标语言: -
结果 (简体中文) 1: [复制]
复制成功!
测量和主要结果:<br>干预部分的主要终点是干预<br>前和干预后尿液[ 金属蛋白酶组织抑制剂-2] * [胰岛素样生长因子结合蛋白7]的变化。为了检查包括急性肾损伤发生率在内的辅助目标,我们<br>纳入了一个观察性队列。<br>试验共纳入180名患者(n = 80观察者和n = 100随机对照部分[20患者/组])。平均年龄为<br>69.3岁(10.5岁),其中119人为男性(66.1%)。在所有偏远地区<br>,[金属蛋白酶-2抑制剂] * [胰岛素样生长<br>因子结合蛋白7]的绝对变化均显着较高。<br>与对照组相比,缺血预处理组<br>(p <0.01)。尽管我们<br>在四个不同的远程缺血预处理组中未观察到[金属蛋白酶2的组织抑制剂] * [胰岛素样生长因子结合蛋白7]的绝对变化的剂量反应关系,但在<br>15个对最低剂量无效的患者中,有九名(60%)<br>对更高剂量的后续治疗有反应。与对照组相比,较少的接受远程缺血<br>预处理的患者在<br>两种肾脏疾病定义的手术后72小时内出现急性肾损伤:改善<br>总体结果标准(30/80 [37.5%] vs 61/100 [61.0%];<br>p = 0.003)。
正在翻译中..
结果 (简体中文) 2:[复制]
复制成功!
Measurements and Main Results: The primary endpoint of the <br>interventional part was change in urinary [tissue inhibitor of <br>metalloproteinases-2]*[insulin-like growth factor–binding protein 7] between pre- and postintervention. To examine secondary objectives including acute kidney injury incidence, we <br>included an observational cohort. A total of 180 patients were <br>included in the trial (n = 80 observational and n = 100 randomized controlled part [20 patients/group]). The mean age was <br>69.3 years (10.5 yr), 119 were men (66.1%). Absolute changes <br>in [tissue inhibitor of metalloproteinases-2]*[insulin-like growth <br>factor–binding protein 7] were significantly higher in all remote <br>ischemic preconditioning groups when compared with controls <br>(p < 0.01). Although we did not observe a dose-response relationship on absolute changes in [tissue inhibitor of metalloproteinases-2]*[insulin-like growth factor–binding protein 7] across <br>the four different remote ischemic preconditioning groups, in the <br>15 patients failing to respond to the lowest dose, nine (60%) <br>responded to a subsequent treatment at a higher intensity. Compared with controls, fewer patients receiving remote ischemic <br>preconditioning developed acute kidney injury within 72 hours <br>after surgery as defined by both Kidney Disease: Improving <br>Global Outcomes criteria (30/80 [37.5%] vs 61/100 [61.0%]; <br>p = 0.003).
正在翻译中..
结果 (简体中文) 3:[复制]
复制成功!
主要测量结果和终点<br>介入部分为尿[组织抑制物]改变<br>干预前后金属蛋白酶-2]*[胰岛素样生长因子结合因子7]。为了检查次要目标,包括急性肾损伤的发生率,我们<br>包括一个观察队列。共有180名患者<br>纳入试验(n=80个观察组,n=100个随机对照组[20名患者/组])。平均年龄是<br>69.3岁(10.5岁),男性119例(66.1%)。绝对变化<br>[金属蛋白酶组织抑制剂-2]*[胰岛素样生长<br>因子结合蛋白7]在所有远端组织中显著升高<br>缺血预处理组与对照组比较<br>(p<0.01)。尽管我们没有观察到金属蛋白酶组织抑制剂-2]*[胰岛素样生长因子-结合蛋白7]的绝对变化的剂量-反应关系<br>四个不同的远程缺血预处理组<br>15名患者对最低剂量无效,9名(60%)<br>对随后的高强度治疗有反应。与对照组相比,接受远端缺血的患者更少<br>预处理在72小时内发生急性肾损伤<br>术后两种肾脏疾病的定义:改善<br>全球结果标准(30/80[37.5%]vs 61/100[61.0%];<br>p=0.003)。<br>
正在翻译中..
 
其它语言
本翻译工具支持: 世界语, 丹麦语, 乌克兰语, 乌兹别克语, 乌尔都语, 亚美尼亚语, 伊博语, 俄语, 保加利亚语, 信德语, 修纳语, 僧伽罗语, 克林贡语, 克罗地亚语, 冰岛语, 加利西亚语, 加泰罗尼亚语, 匈牙利语, 南非祖鲁语, 南非科萨语, 卡纳达语, 卢旺达语, 卢森堡语, 印地语, 印尼巽他语, 印尼爪哇语, 印尼语, 古吉拉特语, 吉尔吉斯语, 哈萨克语, 土库曼语, 土耳其语, 塔吉克语, 塞尔维亚语, 塞索托语, 夏威夷语, 奥利亚语, 威尔士语, 孟加拉语, 宿务语, 尼泊尔语, 巴斯克语, 布尔语(南非荷兰语), 希伯来语, 希腊语, 库尔德语, 弗里西语, 德语, 意大利语, 意第绪语, 拉丁语, 拉脱维亚语, 挪威语, 捷克语, 斯洛伐克语, 斯洛文尼亚语, 斯瓦希里语, 旁遮普语, 日语, 普什图语, 格鲁吉亚语, 毛利语, 法语, 波兰语, 波斯尼亚语, 波斯语, 泰卢固语, 泰米尔语, 泰语, 海地克里奥尔语, 爱尔兰语, 爱沙尼亚语, 瑞典语, 白俄罗斯语, 科西嘉语, 立陶宛语, 简体中文, 索马里语, 繁体中文, 约鲁巴语, 维吾尔语, 缅甸语, 罗马尼亚语, 老挝语, 自动识别, 芬兰语, 苏格兰盖尔语, 苗语, 英语, 荷兰语, 菲律宾语, 萨摩亚语, 葡萄牙语, 蒙古语, 西班牙语, 豪萨语, 越南语, 阿塞拜疆语, 阿姆哈拉语, 阿尔巴尼亚语, 阿拉伯语, 鞑靼语, 韩语, 马其顿语, 马尔加什语, 马拉地语, 马拉雅拉姆语, 马来语, 马耳他语, 高棉语, 齐切瓦语, 等语言的翻译.

Copyright ©2024 I Love Translation. All reserved.

E-mail: